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Detection of Small Hypervascular Hepatocellular
Carcinomas in Cirrhotic Patients: Comparison of
Superparamagnetic Iron Oxide-Enhanced MR
Imaging with Dual-Phase Spiral CT
Objective: To compare the performance of superparamagnetic iron oxide
(SPIO)-enhanced magnetic resonance (MR) imaging at 1.5T and dual-phase spi-
ral computed tomography (CT) for the depiction of small hypervascular hepato-
cellular carcinomas (HCCs).
Materials and Methods: Forty-three patients with 70 small nodular HCCs (5
20 mm; mean, 13.7 mm) were examined. Diagnosis was based on the results of
surgical biopsy in 22 patients and by the combined assessment of MR imaging,
lipiodol CT, alpha feto-protein levels, and angiographic findings in 21. MR imag-
ing consisted of respiratory-triggered turbo spin-echo T2-weighted imaging, T1-
weighted fast low-angle shot, and T2 -weighted fast imaging with steady-state
precession imaging before and after SPIO enhancement. CT imaging was per-
formed with 5-mm collimation and 1:1.4 pitch, and began 30 and 65 secs after the
injection of 150 mL of contrast medium at a rate of 3 mL/sec. Two blinded
observers reviewed all images independently on a segment-by-segment basis.
Diagnostic accuracy was evaluated using receiver operating characteristics
(ROC) analysis.
Results: The mean areas (Az) under the ROC curves were 0.85 for SPIO-
enhanced MR imaging and 0.79 for dual-phase spiral CT (p < .05). The mean
sensitivity of SPIO-enhanced MR imaging was significantly higher than that of CT
(p < .05), i.e. 70.6% for MR imaging and 58.1% for CT. MR imaging had higher
false-positive rates than dual-phase spiral CT, but the difference was not statisti-
cally significant (3.7% vs 3.3%) (p > .05). 
Conclusion: SPIO-enhanced MR imaging is more sensitive than dual-phase
spiral CT for the depiction of small hypervascular hepatocellular carcinomas.
epatocellular carcinoma (HCC) is one of the most common globally oc-
curring malignant neoplasms. Although hepatic resection is an effective
treatment for HCC patients, the resectability, operative mortality, and
prognosis for small HCCs differ from those for larger tumors such as those usually
found in patients presenting with symptoms (1 5). For large tumors, the operative
mortality rate ranges from 6.7% to 36% (3 4), but for small tumors, this rate is 3-
12.5% (5). In addition, the five-year survival rate is much better for smaller than for
larger tumors. The need for a preoperative imaging modality that can detect small
HCCs prior to the appearance of clinical symptoms is thus of great importance in clini-
cal practice. 
Contrast-enhanced spiral CT is the most widely used imaging technique for the de-
tection and characterization of focal hepatic lesions. Various studies have shown that
the use of dual-phase spiral CT imaging during both the arterial and portal venous
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Hphases of enhancement leads to further improvement in
the detection rates of hypervascular tumors such as HCC
(6 8). However, the detection of hepatocellular carcinoma
and hepatocytic nodules such as dysplastic nodules is diffi-
cult because cirrhotic liver parenchyma contains fibrosis,
regenerative nodules, fatty infiltration, and parenchymal
necrosis (9). Currently, MR imaging is increasingly utilized
for the detection of hepatic lesions, and the use of super-
paramagnetic iron oxide (SPIO), a tissue-specific contrast
agent, has the potential to increase the sensitivity and
specificity of hepatic MR imaging (10 12). To our knowl-
edge, no study has focused on the comparison of dual-
phase contrast-enhanced spiral CT and SPIO-enhanced MR
imaging for the detection of small HCCs (less than 2 cm).
In the present study, we compare the performance of MR
imaging after the administration of SPIO with that of dual-
phase contrast-enhanced CT for the detection of small-di-
ameter hypervascular HCCs using receiver operating char-
acteristics (ROC) analysis.
SUBJECTS AND METHODS
Patients 
Between October 1998 and January 2002, 120 patients
with suspected focal liver tumors underwent dual-phase
spiral CT, unenhanced MR imaging, and SPIO-enhanced
MR imaging. We excluded 77 of these, as follows: 49 with
HCCs larger than 2 cm in diameter; seven in whom hyper-
vascularity of the tumor was not apparent at selective he-
patic angiography; seven who underwent radiofrequency
thermal ablation; five who underwent surgery more than 4
weeks after CT or MRI; and nine who, after transcatheter
arterial chemoembolization (TACE), were not available for
follow-up studies of at least 6 months due to a lack of firm
evidence of a true-negative segment. The remaining 43 pa-
tients, for whom there was acceptable proof of the pres-
ence of small hypervascular hepatocellular carcinoma (less
than 2 cm in diameter), and who had liver cirrhosis, were
included in this study. 
In all these patients, liver cirrhosis was determined by
clinical examination and blood chemistry tests (aspartate
aminotransferase, alanine aminotransferase, alkaline phos-
phatase, bilirubin, albumin, and globulin). The interval be-
tween SPIO-enhanced MR imaging and dual-phase spiral
CT was not greater than one month. Direct comparison be-
tween MR imaging and CT was made in each imaging sec-
tion of the liver.
Lesion Confirmation
A total of 43 patients with 70 small HCCs (5 20 mm,
mean 13.7 mm) were enrolled in the study. Twelve pa-
tients had two HCCs, one patient had three, three patients
had four, and one patient had five, and in each of the re-
maining 26 patients, one nodule was present. Proof of hy-
pervascular HCC was confirmed using a combination of
pathologic and angiographic findings (n=25) or a combina-
tion of angiographic and lipiodol CT findings (n=45).
Seventeen patients with 20 lesions underwent hepatic re-
section and intraoperative ultrasonography. In five pa-
tients, only one attempt was made to perform percuta-
neous biopsy of a single lesion per patient, but in three, ad-
ditional lesions were detected by both lipiodol and angio-
graphic CT. For the other 21 patients with 39 lesions who
underwent TACE, the presence of individual malignant le-
sions was confirmed by means of elevated serum  FP lev-
els, angiographic findings, and lipiodol CT uptake. 
Subsegmental TACE was performed by injecting a
chemotherapeutic drug emulsion, followed by gelatin
sponge particles (Gelfoam; Pharmacia-Upjohn, Mich,
U.S.A.), as previously described (13). The emulsion con-
sisted of lipiodol (Guerbet, Aulnay-sous-Bois, France) ,
doxorubicin hydrochloride (Adriamycin; Ildong Pharm
Co., Seoul, Korea) and non-ionic contrast material
(Ultravist 300; Schering, Berlin, Germany ). After perform-
ing subsegmental TACE, 2 3 mL of lipiodol was injected
into the proper hepatic artery in order to detect hidden
HCC at subsequent lipiodol CT, performed using a
Somatom Plus-4 scanner (Siemens Medical Systems,
Erlangen, Germany) with 5-mm slice thickness two weeks
after TACE. The diagnostic criterion for HCC at lipiodol
CT was a round, dense deposit of iodized oil after TACE in
which this oil was used (14). 
Follow-up CT examinations were performed 6 36
months later in all patients who had undergone resective
surgery or TACE. Proof of the absence of HCC nodules in
hepatic segments was provided by negative findings at in-
traoperative ultrasonography, or a combination of no
nodular lipiodol uptake at lipiodol CT and no evidence of
further nodular growth at follow-up CT.
MR Imaging Examinations
All MR imaging was performed on a 1.5-T system
(Magnetom Vision; Siemens, Erlangen, Germany) using a
phased-array coil for signal reception. Baseline MR images
were acquired with a respiratory-triggered T2-weighted
turbo spin-echo (TSE) sequence, a breath-hold T2*-weight-
ed fast imaging with steady-state precession (FISP) se-
quence, and a breath-hold T1-weighted fast low-angle shot
(FLASH) sequence.
Respiratory-triggered T2-weighted TSE imaging (TR
range/TE, 3300 5500/85) was performed with an echo-
train length of 5, a 120 256 matrix, and two signal aver-
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flip angle, matrix of 96 256, one signal average) was fol-
lowed by breath-hold T1-weighted FLASH imaging (120/4,
80 flip angle, matrix of 140 256, one signal average).
All images were obtained in the transaxial plane, using a
phased-array multicoil. For all sequences, a 7-mm slice
thickness was used, with a 10% intersection gap and a field
of view of 35 40 cm, depending on the size of the liver. 
SPIO-enhanced MR imaging comprised the respiratory-
triggered T2-TSE sequence, the breath-hold T2*-weighted
FISP sequence, and the breath-hold T1-weighted FLASH
sequence, with the same parameters as those used in base-
line MR imaging. The SPIO agent (Feridex; Advanced
Magnetics, Cambridge, Mass., U.S.A.), was administered at
a dose of 15  mol of iron per kilogram of body weight,
was diluted in 100 mL of 5% dextrose solution and inject-
ed intravenously through a specific 5  filter for 30 mins;
imaging commenced approximately 70 (range, 50 90)
mins after the intravenous infusion of SPIO.
CT Examinations
For dual phase contrast-enhanced spiral CT, a Somatom
plus 4 scanner (Siemens Medical Systems, Erlangen,
Germany) was used. The scanning parameters were 120
kVp, 240 mA, 5-mm collimation, table speed of 7-mm/sec,
and a 5-mm reconstruction interval. After unenhanced spi-
ral liver scanning, the arterial phase was begun 30 secs af-
ter the power injection of 150 mL of nonionic contrast ma-
terial (Iopromide [Ultravist 370]; Schering, Berlin,
Germany) at a rate of 3 mL/sec. Portal phase scanning was
begun 65 secs after the start of contrast injection. 
Imaging Analysis (Receiver Operating Characteristics
Analysis, ROC)
Before performing ROC analysis, a gold standard for the
lesions to be investigated was defined by two experienced
abdominal radiologists, who coordinated ROC analysis and
reached their decisions by consensus. They analyzed all the
images obtained as well as the operative, laboratory, and
histological findings, evaluating a total of 70 separate focal
HCC lesions smaller than 2 cm in diameter.
Two other independent observers, both experienced ab-
dominal radiologists, reviewed the contrast-enhanced spi-
ral CT and SPIO-enhanced MR images. They were in-
formed only that the patients with liver cirrhosis were re-
ferred for preoperative assessment of suspected liver ma-
lignancy. Images were reviewed on a segment-by-segment
basis, and to avoid incorrect localization of the lesions, he-
patic segmentation according to the Couinaud numbering
system was drawn directly. A total of 344 segments (61 of
which contained 70 HCC nodules, and 283 segments with-
out proof of the presence of HCC lesions) were reviewed.
Five of the 61 segments contained more than two nodules,
and to ensure correct localization, each observer recorded
the image number and size of each lesion, and added fur-
ther comments. 
Each observer read two sets of images (set 1: unen-
hanced and SPIO-enhanced turbo spin-echo, T1-weighted
FLASH, and T2*-weighted FISP images; set 2: pre- and
post-contrast dual-phase spiral CT images), with an inter-
val of at least a week between the two readings. Each
recorded the presence and location of one or more lesions,
assigning to each a confidence level on a five-point scale:
‘1’ was defined as ‘definitely or almost definitely absent’;
‘2’ as ‘probably absent’; ‘3’ as ‘possibly present’; ‘4’ as
‘probably present’; and ‘5’ as ‘definitely or almost definite-
ly present’. 
For each imaging set, a binomial ROC curve was fitted to
each reviewer’s confidence rating data using a maximum
likelihood estimation (ROCKIT 0.9, Charles E. Metz). The
diagnostic accuracy of each imaging modality was deter-
mined by calculating the area (A index, Az) under each ob-
server-specific binomial ROC curve plotted in the designed
square. The composite ROC curves used to represent the
combined performance of the two observers were calculat-
ed for each set of images using Rockit 0.9 software to rate
their pooled data. The differences between imaging modal-
ities in terms of the mean areas under the ROC curves
were statistically analyzed using the two-tailed Student
t test for paired data. To determine relative sensitivity for
HCC, the number of segments assigned level 3 or more
from among the 70 HCC nodules was noted. The relative
sensitivities and specificities for HCC obtained from the
two radiologists’ and pooled data were calculated for each
modality, and to ascertain the differences between the
imaging modalities and between observers, multiple com-
parisons involving Student’s t test were made. A two-tailed
p value of less than 0.05 was considered significant. 
Agreement between blinded observers is reported below
in terms of kappa values, those greater than 0 indicating
positive correlation. Values of up to 0.4 indicated positive
but poor correlation; those of 0.41 0.75 indicated good
correlation.
RESULTS
For all 70 lesions, the calculated areas under the ROC
curves and the mean area for the two observers for each
imaging modality are shown in Table 1. For each modality,
ROC curves drawn on the basis of the data pooled by the
two observers are shown in Figure 1. In terms of lesion de-
tection, both agreed that performance using the set of
Superparamagnetic Iron Oxide-Enhanced MR vs. Dual-Phase Spiral CT in Detection of Small Hypervascular Hepatocellular Carcinomas 
Korean J Radiol 4(1), March 2003 3SPIO-enhanced MR images was significantly superior to
that obtained at dual-phase spiral CT imaging (p < .05).
The mean area under both observers’ ROC curves was
0.85 for pre- and post-SPIO-enhanced MR imaging and
0.79 for pre- and post-contrast dual-phase spiral CT imag-
ing; this difference was statistically significant (p < .05). 
Sensitivities and specificities were calculated for each ob-
server and for each modality, and mean values were also
determined (Table 2). The combination of SPIO-enhanced
MR images was 12.5% more sensitive than that of dual-
phase spiral CT images (MR, 70.6%; CT, 58.1%), a statisti-
cally significant difference (p < .05). In 18 cases, tumor
nodules were detected at MR imaging, but not at CT. In 12
cases, nodules were smaller than 1cm (Fig. 2). In two cases,
additional lesions were detected only at CT; in one of
these, because the high signal intensity of the gallbladder
(GB) interfered with the signal intensity of the true nodule,
found at T2-weighted imaging to also be high, the ob-
servers missed a 5-mm subcapsular nodule abutting the
GB. In the other case, a small nodule was not detected be-
cause of the presence of severely injured liver parenchyma
of heterogeneous texture. In addition, 11/70 lesions
(15.7%) in ten patients were not detected by any modality.
Lee et al.
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Fig. 2. In this 63-year-old man, a 0.8-cm hepatocellular carcinoma was found in segment I.
A. Neither the arterial-phase CT image (left) nor the portal venous-phase CT image (right) revealed the presence of a lesion. 
B. SPIO-enhanced respiratory-triggered T2-weighted turbo spin-echo image (left) and breath-hold T2*-weighted fast image obtained
with steady state precession (right) depict the tumor as an area of high signal intensity (arrows). Its presence was surgically confirmed. 
AB
Fig. 1. ROC curves describe observer confidence in the detection
of hepatocellular carcinomas depicted at pre- and post-SPIO-en-
hanced MR imaging involving T1-weighted FLASH, T2-weighted
TSE, and T2 -weighted FISP sequences (diamonds), and anoth-
er set obtained at contrast-enhanced dual-phase spiral CT
(squares). Note that observers showed more confidence in inter-
preting MR images than dual-phase spiral CT images (p < .05). 
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Table 1. Individual and Mean Areas Under the Curve for Pre-
and Post-SPIO-Enhanced MR and Dual-Phase Spiral
CT (All Lesions)
Imaging Modality
Az Index
Observer 1 Observer 2 Mean
CT imaging 0.80 0.03 0.78 0.04 0.79 0.02
MR imaging 0.86 0.03 0.85 0.03 0.85 0.02
Note. Values are expressed as mean SD.
For the comparison of MR imaging with CT, p < .05
Table 2. Sensitivity and Specificity of Pre- and Post-SPIO-
Enhanced MR and Dual-Phase Spiral CT (All
Lesions)
Imaging Modality
Az Index
Observer 1 Observer 2 Mean
CT
Sensitivity 58.8 57.4 58.1
Specificity 96.5 96.9 96.7
MR
Sensitivity 72.1 69.1 70.6
Specificity 96.2 95.5 95.8
Note. Numbers are percentages.
For the comparison of MR imaging with CT, p < .05Of these false-negative lesions, three were confirmed by
percutaneous biopsy, two by surgical resection and biopsy,
and the remaining six by lipiodol CT. Except for one with
a diameter of 2 cm, these missed lesions ranged in size
from 0.5 to 1.0 cm. The 2.0-cm nodule was located in the
subcapsular dome of segment VIII and was therefore misin-
terpreted at both CT and MR imaging as a partial volume
artifact of the cardiac structure. 
In terms of specificity, CT was superior to MR imaging
(96.7% versus 96.3%) though this difference was not sta-
tistically significant (p > .05). At CT, the observers detect-
ed 13 false-positive lesions, all of which were attributed to
the perfusion artifact (Fig. 3), and at MR imaging, a total of
15 false-positive lesions were detected; most were attrib-
uted to misdiagnosis of the intrahepatic vessels as tumor
nodules (Fig. 4). 
For CT and MR imaging, kappa values for the two ob-
servers were 0.698 and 0.723, respectively, indicating
good inter-observer agreement.
DISCUSSION
Recent studies have shown that for the detection of focal
hepatic lesions, SPIO-enhanced MR imaging is consider-
ably more sensitive than conventional contrast-enhanced
CT and unenhanced MR imaging, and is at least as accurate
as CT during arterial portography (CTAP) (15 21). In ad-
dition, previous studies have indicated that the results of
SPIO-enhanced MR imaging were comparable to those of
dual-phase contrast-enhanced CT (20). However, unlike
metastatic tumors, most HCCs occur in chronically injured
liver tissue that shows less response to iron oxide particles
than does normal liver tissue (22). 
In this study, we compared the accuracy of SPIO-en-
hanced MR imaging and dual-phase spiral CT for the de-
tection of small HCCs in patients with liver cirrhosis, show-
ing that the former was more accurate than the latter (p <
.05). ROC analysis indicated that both observers per-
formed better with SPIO-enhanced MR imaging than with
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AB
Fig. 3. In this 65-year-old man, spiral CT imaging revealed false-
positive lesions.
A. CT image obtained during the arterial phase depicts three
high-attenuation foci (arrows). 
B. Portal venous-phase CT image shows no apparent abnormal-
ity.
C. SPIO-enhanced respiratory-triggered T2-weighted turbo spin-
echo image (4459/85) obtained at the same level as A shows no
abnormalities. Because there was no lipiodol uptake during post-
transhepatic arterial chemoembolization, the lesions were inter-
preted as perfusion abnormalities. 
Cspiral CT (Table 1). 
In this study, the sensitivity of SPIO-enhanced MR imag-
ing was relatively low compared to the findings of previous
reports (15 17, 19) (Table 2). This difference arose, we
believe, because the tumors were small and because liver
enhancement was poor due to the decreased activity of
Kupffer’s cells. In addition, more prominent visualization
of the reticular fibrosis occurring in cirrhotic liver and the
difficulty of differentiating vascular structures from small
tumor nodules may be important causes of the lower sensi-
tivity of MR imaging, compared with previous findings.
Because of these problems with SPIO-enhanced MR imag-
ing, the sensitivity of HCCs smaller than 2 cm showed no
further increase. Other reports, however, have noted a
similar sensitivity for lesions less than 2 cm in diameter
(20); Choi et al. (17) mentioned that in their series, the le-
sions missed at MR imaging were also smaller than 2 cm. 
The specificity of dual-phase spiral CT was similar to that
of SPIO-enhanced MR imaging (Table 2). The former
showed false-positive findings involving lesions arising
from a small arteriovenous shunt. Because an arterioportal
shunt is detected as a hyperenhancing focus during the ar-
terial dominant phase of dynamic studies and as a portal
venous perfusion defect similar to hepatocellular carcino-
ma at CTAP, a non-tumorous arterioportal shunt in cir-
rhotic liver can sometimes mimic HCC at dynamic CT (23,
24). The administration of SPIO led to decreased hepatic
parenchymal signal intensity, and the enhanced vascular
structure was thus seen as a focal nodular form and was
misinterpreted as a nodule. In addition, clearer visualiza-
tion of the parenchymal fibrosis occurring in cirrhotic liver
made it difficult to differentiate fibrosis from a tumor.
According to previous reports regarding the value of SPIO-
enhanced MR imaging for the detection of focal liver le-
sions, the high signal intensity of vascular structures (ves-
sels mimicking nodules) was the most frequent cause of
false-positive interpretations (17, 19). 
Our choice of MR sequence before and after SPIO en-
hancement requires further explanation. To achieve the
best results that SPIO can provide, the selection of suitable
pulses is essential. To maximize the detection of small
HCCs, we obtained a set of pre- and post-SPIO-enhanced
images using a T2*-weighted FISP sequence, T1-weighted
FLASH imaging, and a respiratory-triggered T2-weighted
TSE sequence. It is clear from various comparative studies
that gradient-recalled echo pulse sequences can be used to
enforce local field inhomogeneities to T2* relaxation and
to achieve brilliant lesion-to-liver contrast (16, 25 28). In
addition, we used respiratory-triggered TSE imaging rather
than conventional spin-echo or breath-hold TSE imaging.
Because TSE sequences use more refocusing pulses and are
less prone to the magnetic susceptibility effect, convention-
al spin-echo imaging is more sensitive than TSE (26, 27). In
addition, at many institutions, breath-hold TSE imaging has
replaced conventional spin-echo or respiratory-triggered
TSE imaging for routine T2-weighted imaging of the liver.
However, we used a respiratory-triggered TSE sequence
for two reasons: because the conventional spin-echo se-
quence, which requires prolonged acquisition time, increas-
es the imaging artifact in cirrhotic patients, and because as-
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Fig. 4. In this 45-year-old man, a false-positive lesion was seen at SPIO-enhanced MR imaging.
A. SPIO-enhanced breath-hold T2 -weighted fast MR image obtained with steady-state precession (180/12, 30 flip angle) reveals a
high-signal-intensity focal area (arrow). 
B. Arterial-phase CT image obtained at the same level as A depicts no abnormalities. The presence of this false-positive lesion at MRI is
attributed to misinterpretation of the vessel as a tumor nodule.
ABcites formation related to poor liver function in patients
with liver cirrhosis makes long breath-holding very diffi-
cult. Because a benign cyst shows low signal intensity at
SPIO-enhanced MR imaging, despite the high signal inten-
sity of other malignant lesions, and an hemangioma shows
increased signal intensity at SPIO-enhanced T1-weighted
imaging (29, 30), we used the T1-weighted gradient-echo
sequence to differentiate HCC from hemangioma and cyst.
This study suffers certain limitations. First, there was in-
sufficient histopathologic confirmation of the presence of
liver lesions. Although most lesions not subject to biopsy
probably represent additional sites of HCC or true-positive
lesions, some false-positive lesions might have been includ-
ed in our study. Second, because only 17 patients under-
went surgery and intraoperative ultrasonography, it was
not absolutely certain that in segments apparently without
HCC nodules, these were in fact absent (true negative).
However, we used relatively strict criteria for the standard
of reference regarding true-negative segments, i.e. negative
CT findings after the arterial infusion of iodized oil were
combined with follow-up CT at least six months later.
Third, we performed arterial and portal phase imaging af-
ter contrast injection. Because some small HCCs may show
iso-attenuation to surrounding liver parenchyma at portal
phase imaging, the inclusion of equilibrium phase imaging
may increase the likelihood of observing the contrast
washout effect of HCCs and therefore improve the detec-
tion rate for small HCCs (31, 32). Last, the spiral CT tech-
nology used in this study was not state of the art.
Multidetector spiral CT now permits the use of thinner
slice thicknesses and better time resolution than is possible
with single-detector mode (33), and we believe that its use
may improve the accuracy of CT examinations for the
evaluation of focal liver tumors.
In conclusion, MR imaging performed before and after
the administration of SPIO contrast material and involving
combined T2- and T2*- weighted sequences and an addi-
tional T1-weighted sequence is more sensitive and accurate
than dual-phase spiral CT imaging for the detection of
small HCCs. To detect these, a set of SPIO-enhanced MR
imaging sequences can thus be used in place of dual-phase
spiral CT imaging as a preoperative diagnostic strategy in
patients with cirrhosis or other chronic disease of the liver. 
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